| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 02/28/2007 | EP1757606A1 Xanthinderivatives, preparation thereof and their use as medical agents |
| 02/28/2007 | EP1757582A1 Arylalkylamines and process for production thereof |
| 02/28/2007 | EP1757290A1 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 02/28/2007 | EP1755636A1 Sustained release composition |
| 02/28/2007 | EP1755572A2 N- (2-benzyl) -2-phenylbutanamides as androgen receptor modulators |
| 02/28/2007 | EP1492771B1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents |
| 02/28/2007 | EP1320541B1 Tgf-beta inhibitors and methods |
| 02/28/2007 | EP1272186B1 Therapeutic combinations of antihypertensive and antiangiogenic agents |
| 02/28/2007 | EP1151756B1 Kit comprising polyacrylamide gel for forming a capsule in the tissue of a mammal organism and allogenic or xenogenous cells of an animal, method for therapy of oncological diseases and the diabetes mellitus |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | EP1025077B1 Novel aryloxy-alkyl-dialkylamines |
| 02/28/2007 | CN1922183A Nitrogenous fused heteroaromatic ring derivative |
| 02/28/2007 | CN1920036A Macaque progesterone acceptor gene fragment and application thereof |
| 02/28/2007 | CN1919277A Application of pharmaceutical composition in the process for preparing medicine of enhancing insulin sensitivity |
| 02/28/2007 | CN1302007C Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 02/28/2007 | CN1301997C Benzosulfones with calcium antagonist activity |
| 02/28/2007 | CN1301710C Therapeutic methods and compositions involving isoflavones |
| 02/27/2007 | US7183445 4-(4-Hydroxy-phenyl)-[4-(2-morpholin-4-yl-ethoxy)-benzyl]-methyl-cyclohex-3-enecarboxylic acid ethyl ester; estrogen receptor modulators for hot flashes, vaginal dryness, osteopenia, osteoporosis, hyperlipidemia, loss of cognitive function, degenerative brain diseases |
| 02/27/2007 | US7183415 Melanin-concentrating hormone antagonistic action for treating obesity, for example 4'-fluoro-N-[8-methyl-3-(1-pyrrolidinylmethyl)-7-quinolinyl][1,1'-biphenyl]-4-carboxamide |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183260 C-terminal modified oxamyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/27/2007 | US7183078 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders |
| 02/27/2007 | US7182960 Pharmaceutical compositions for nasal delivery of oestradiol and norethisterone |
| 02/22/2007 | WO2006128852A3 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 02/22/2007 | WO2006069202A3 Compositions comprising anti-igf-i receptor antibodies and methods for obtaining said antibodies |
| 02/22/2007 | WO2006002185A8 Chemical compounds |
| 02/22/2007 | US20070043095 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 02/22/2007 | US20070043077 Aryl-carbaldehyde oxime derivatives and their use as estrogenic agents |
| 02/22/2007 | US20070043007 Specific glucocorticosteroid compounds having anti-inflammatory activity |
| 02/22/2007 | US20070043005 Treatment of hyperproliferative diseases using high doses of active vitamin d |
| 02/22/2007 | US20070042999 Phosphate derivatives of pharmaceutical products |
| 02/22/2007 | US20070042941 Galectin 9-inducing factors |
| 02/22/2007 | US20070042048 Devices, Compositions and Methods for the Pulmonary Delivery of Aerosolized Medicaments |
| 02/22/2007 | CA2620280A1 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 02/21/2007 | EP1753749A1 Novel indole derivatives as selective androgen receptor modulators (sarms) |
| 02/21/2007 | EP1753435A1 Use of a combination of ethinyl estradiol and chlormadinone acetate for the production of a medicament |
| 02/21/2007 | EP1523325A4 Methods and compositions for treating polycystic ovary syndrome |
| 02/21/2007 | EP1519726B1 Utilization of heteroarene carboxamide as dopamine-d3 ligands for the treatment of cns diseases |
| 02/21/2007 | EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/21/2007 | CN1918128A Fused ring 4-oxopyrimidine derivative |
| 02/21/2007 | CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same |
| 02/21/2007 | CN1918113A Androgen receptor modulators |
| 02/21/2007 | CN1915344A Nutrient for cell growth, preparation method, and application of finished product in treating tumor, cardiovascular and cerebrovascular diseases |
| 02/21/2007 | CN1915231A Use of nonsteroidal in preparing drug of antiinflammatory agents |
| 02/20/2007 | US7179922 Chemical compounds |
| 02/20/2007 | US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
| 02/20/2007 | US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/20/2007 | US7179802 reducing the risk of developing a condition selected from the group consisting of hypercholesterolemia, atherosclerosis, low HDL levels, high LDL levels, hyperlipidemia, hypertriglyceridemia and dyslipidemia |
| 02/20/2007 | US7179610 Characterizing the existence of a disease state; particularly to the utilization of mass spectrometry to elucidate particular biopolymer markers indicative or predictive of a particular disease state |
| 02/20/2007 | CA2344574C Thyroid receptor ligands |
| 02/15/2007 | WO2007018583A2 Human growth hormone conjugated with biocompatible polymer |
| 02/15/2007 | WO2007018319A1 Pyridylphenol compound and use thereof |
| 02/15/2007 | WO2007018248A1 Pyridone compound |
| 02/15/2007 | WO2007017423A2 Pharmaceutical composition comprising a dpp-iv inhibitor |
| 02/15/2007 | US20070037884 Novel succinate salt of O-desmethyl-venlafaxine |
| 02/15/2007 | US20070037772 Pyrazolidinol compounds |
| 02/15/2007 | US20070037750 Exendin agonist composed of a peptide in which at least one amino acid residue is acylated with a dicarboxylic acid; the amino acid residues are an internal lysine residue, an N-terminal amino acid residue, and/or a C-terminal amino acid residue; treatment of glucagonoma |
| 02/15/2007 | US20070037218 Human gene critical to fertility |
| 02/15/2007 | US20070036780 Modified proteins, designer toxins, and methods of making thereof |
| 02/15/2007 | CA2618112A1 Pyridone compound |
| 02/15/2007 | CA2617715A1 Pharmaceutical composition comprising a dpp-iv inhibitor |
| 02/14/2007 | EP1752452A1 Propane-1,3-dione derivative or its salt |
| 02/14/2007 | EP1752189A2 Microprojection array having a beneficial agent containing coating |
| 02/14/2007 | EP1752155A1 Compositions for correcting age related changes of a human endocrine system and methods for producing a pharmaceutical form bases on said compositions |
| 02/14/2007 | EP1752146A1 Therapeutic agent for diabetes |
| 02/14/2007 | EP1751189A1 Diagnostic and therapeutic applications of soluble lhcgr protein |
| 02/14/2007 | EP1750756A2 Compositions and methods for enhanced mucosal delivery of parathyroid hormone |
| 02/14/2007 | EP1750730A2 Treatment of hypercholesterolemia, hypertriglyceridemia and cardiovascular-related conditions using phosphalipase-a2 inhibitors |
| 02/14/2007 | EP1750699A2 Treatment of diet-related conditions using phospholipase-a2 inhibitors comprising indoles and related compounds |
| 02/14/2007 | EP1507514B1 Controlled release compositions of estradiol metabolites |
| 02/14/2007 | EP1442059B1 Analogs of human growth hormone-releasing hormone, their preparation and use |
| 02/14/2007 | EP1417228B1 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 02/14/2007 | EP1368349B1 Xanthine derivative, production and use thereof as a medicament |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1066030B1 Topical hormonal composition with systemic effect |
| 02/14/2007 | CN1914215A Vanadium compounds as inhibitors of phosphatases |
| 02/14/2007 | CN1911965A Binding domain-immunoglobulin fusion proteins |
| 02/14/2007 | CN1911925A 3,4-dihydro-III 2 benzopyran-1 ketone kind compound, its preparation method and use |
| 02/14/2007 | CN1911438A 血管新生诱导剂 Angiogenic inducer |
| 02/14/2007 | CN1911241A Slow-released type iodine complement agent, and prepn. method and use-thereof |
| 02/14/2007 | CN1911221A Use of a hypoglycemic agent for treating impaired glucose metabolism |
| 02/14/2007 | CN1911206A Water-based shampoo |
| 02/14/2007 | CN1911205A Aqueous hair detergent |
| 02/14/2007 | CN1299686C Combination of semisolid framework preparation of progesterone |
| 02/14/2007 | CN1299672C Extracts from sophora,production method and purposes thereof |
| 02/13/2007 | US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine |
| 02/13/2007 | US7176221 Low dose pharmaceutical composition having uniform drug distribution and potency |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176211 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis |
| 02/08/2007 | WO2007015567A1 Cyclic amine compound |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032538 Use of compounds |
| 02/08/2007 | US20070031375 IL-16 antagonist peptides and DNA encoding the peptides |
| 02/08/2007 | CA2617256A1 Cyclic amine compound |
| 02/08/2007 | CA2613518A1 Use of substituted 5-amino-1h-pyrrole-2-carbonitrile derivatives as progesterone receptor modulators |
| 02/07/2007 | EP1749529A1 Utilisation of heteroarene carboxamide as dopamine-D3 ligands for the treatment of CNS diseases |
| 02/07/2007 | EP1748770A1 Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen |